Home/Filings/4/0001796960-26-000004
4//SEC Filing

Flammer Martina M.D. 4

Accession 0001796960-26-000004

CIK 0001104506other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 5:20 PM ET

Size

19.1 KB

Accession

0001796960-26-000004

Insider Transaction Report

Form 4
Period: 2026-01-06
Flammer Martina M.D.
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-06$26.43/sh+8,570$226,505103,324 total
  • Sale

    Common Stock

    2026-01-06$173.47/sh4,783$829,70798,541 total
  • Sale

    Common Stock

    2026-01-06$174.21/sh2,830$493,01495,711 total
  • Sale

    Common Stock

    2026-01-06$175.01/sh957$167,48594,754 total
  • Sale

    Common Stock

    2026-01-06$173.33/sh1,615$279,92893,139 total
  • Sale

    Common Stock

    2026-01-07$175.84/sh1,434$252,15591,705 total
  • Sale

    Common Stock

    2026-01-08$173.87/sh1,660$288,62490,045 total
  • Sale

    Common Stock

    2026-01-08$174.17/sh3,251$566,22786,794 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2026-01-068,5700 total
    Exercise: $26.43Exp: 2032-01-06Common Stock (8,570 underlying)
Footnotes (8)
  • [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F2]This is the weighted average sales price representing 4,783 shares sold at prices ranging from $172.89 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F3]This is the weighted average sales price representing 2,830 shares sold at prices ranging from $173.92 to $174.80 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F4]This is the weighted average sales price representing 957 shares sold at prices ranging from $174.97 to $175.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F5]Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  • [F6]This is the weighted average sales price representing 1,434 shares sold at prices ranging from $175.72 to $176.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F7]This is the weighted average sales price representing 1,660 shares sold at prices ranging from $173.87 to $173.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F8]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Issuer

INSMED Inc

CIK 0001104506

Entity typeother

Related Parties

1
  • filerCIK 0001796960

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:20 PM ET
Size
19.1 KB